2m 2m 2m 2m 2m 2m 2m
Amphastar Pharma (AMPH)
NASDAQ
$25.45+$0.09 (+0.37%)
Price as of Oct 02, 2026 5:49 PM EDT- $1.1BMarket Cap
- -4.41%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Amphastar Pharma (AMPH)
$25.45+$0.09 (+0.37%)
AMPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $25.35 | ||
Change | -$0.46 (-1.78%) | ||
Open | $25.60 | ||
High | $26.02 | ||
Low | $25.30 | ||
Previous Close | $25.81 | ||
Volume | 530,991 | ||
30-Day Average Volume | 551,194 | ||
1-Week Change | -3.50% | ||
1-Month Change | 10.41% | ||
1-Year Change | -4.41% | ||
3-Year Change | -44.88% | ||
5-Year Change | 31.01% | ||
Fundamentals | |||
Shares Outstanding | 42.5M | ||
Total Assets | $1.7B | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | $30.3M | ||
Free Cash Flow | $42.7M | ||
EBIT | $40.8M | ||
EBITDA | $47.1M | ||
Net Working Capital | $367.7M | ||
EPS | $0.67 | ||
Enterprise Value/EBITDA | 31 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | 38 | ||
PEG | 0 | ||
Price/Free Cash Flow | 25 | ||
Price/Operating Cash Flow | 21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue